Prosight Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Prosight Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-90,176	Closed	-$329K	–	41
2022 Q2	$329K	Buy	+90,176	New	+$426K	0.26%	23
2020 Q4	–	Sell	-277,590	Closed	-$469K	–	57
2020 Q3	$469K	Sell	277,590 -102,355	-27%	-$154K	0.22%	43
2020 Q2	$621K	Buy	379,945 +42,683	+13%	+$84.8K	0.27%	47
2020 Q1	$648K	Buy	337,262 +177,926	+112%	+$467K	0.3%	38
2019 Q4	$454K	Buy	+159,336	New	+$461K	0.2%	38

Other funds holding APEN

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Prosight Management's APEN Position: Q3 2022 in Review

Prosight Management sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2022, closing a stake of 90,176 shares — an estimated $329K sold.

Prosight Management first reported a position in APEN in Q4 2019 and held it in 5 quarters. The position peaked at $648K in Q1 2020. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

Prosight Management reported no remaining Apollo Endosurgery, Inc. position as of Q3 2022 after selling out during the quarter.
Prosight Management sold 90,176 Apollo Endosurgery, Inc. shares in Q3 2022, an estimated $329K.
Prosight Management first reported a position in Apollo Endosurgery, Inc. in Q4 2019 and held it in 5 quarters.
Prosight Management's Apollo Endosurgery, Inc. position peaked at $648K in Q1 2020.
53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on Prosight Management's 13F filing for Q3 2022, filed 14 Nov 2022.